Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when PGNY files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsProgyny reports Q1 2026 earnings results via press release and supplemental presentation
Filed May 7, 2026 · Period ending May 7, 2026 · ~1 min read
Key Changes
-
high
Progyny announced financial results for the quarter ended March 31, 2026, through a press release issued May 7, 2026. Specific financial metrics are contained in the attached exhibits rather than the 8-K body.
Item 2.02 verify on EDGAR → -
medium
The company filed a supplemental earnings presentation alongside the press release, typically containing additional operational metrics and management commentary beyond the headline numbers.
Exhibit 99.2 view on EDGAR → -
low
The 8-K filing itself appears incomplete or truncated, containing only a partial Item 2.02 header in one section, though the complete filing includes proper disclosure of the earnings announcement.
Item 2.02 verify on EDGAR →
Summary
Progyny filed its routine quarterly earnings announcement for the first quarter of 2026, covering the period ended March 31, 2026. The company issued both a press release and a supplemental presentation on May 7, 2026, following standard practice for public company earnings disclosures.
The actual financial results, operational metrics, and management commentary are contained in the attached exhibits rather than in the body of the 8-K itself. For retail investors, this is a standard quarterly earnings filing. The key information—revenue, earnings, guidance, and operational metrics—will be found in the press release (Exhibit 99.1) and supplemental presentation (Exhibit 99.2).
Investors should review these exhibits for the actual financial performance and any forward-looking guidance. Watch for management's commentary on member growth, utilization trends, and any updates to full-year 2026 guidance in the detailed exhibits.
Section-by-Section Diff
Event · Item 2.02 — Results of Operations and Financial Condition
Item 2.02 — Results of Operations and Financial Condition filed; see Key Changes for terms.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
Item 2.02 Results of Operations and Financial Condition and
The 8-K filing contains only a partial Item 2.02 header without any accompanying financial results, operational metrics, or substantive disclosure. This appears to be an incomplete or truncated filing that does not provide the earnings or financial condition information typically expected under Item 2.02.
Event · Item 7.01 — Regulation FD Disclosure
Item 7.01 — Regulation FD Disclosure filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On May 7, 2026, Progyny, Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended March 31, 2026.
The company announced its financial results for the first quarter of 2026 ending March 31, 2026. The actual financial metrics are contained in the press release and supplemental presentation furnished as exhibits, which are not included in this 8-K body text.
Event · Item 9.01 — Financial Statements and Exhibits
Item 9.01 — Financial Statements and Exhibits filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
Press Release of Progyny, Inc. dated May 7, 2026
The company filed a press release dated May 7, 2026, announcing first quarter 2026 earnings results. The 8-K itself does not contain the financial details; those are in the attached exhibit.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify